Latest Breaking News On - Zevra therapeutics daily - Page 1 : comparemela.com

Zevra Therapeutics, Inc (NASDAQ:ZVRA) Receives $19 50 Consensus Price Target from Analysts

Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) has received a consensus rating of “Buy” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have updated their coverage on the stock in the […]

United statesWilliam blairMaxim groupVisionpoint advisory groupZevra therapeutics company profileCommonwealth equity servicesKingsview wealth managementZevra therapeutics incInternational assets investment managementCantor fitzgeraldTower research capitalZevra therapeuticsGet free reportMarketbeat ratingsPoint advisory groupAssets investment management

Roth Capital Equities Analysts Increase Earnings Estimates for Zevra Therapeutics, Inc (NASDAQ:ZVRA)

Roth Capital Equities Analysts Increase Earnings Estimates for Zevra Therapeutics, Inc (NASDAQ:ZVRA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairArmistice capitalMystic asset management incMaxim groupZevra therapeutics incRetirement planning coCantor fitzgeraldJanney montgomery scottEngland incYork mellon corpZevra therapeuticsFree reportRoth capitalZevra therapeuticGet free report

FY2027 EPS Estimates for Zevra Therapeutics, Inc Increased by Analyst (NASDAQ:ZVRA)

FY2027 EPS Estimates for Zevra Therapeutics, Inc Increased by Analyst (NASDAQ:ZVRA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairVisionpoint advisory groupZevra therapeutics incTower research capitalMaxim groupInternational assets investment managementSg americas securitiesCantor fitzgeraldZevra therapeuticsFree reportRoth capitalZevra therapeuticGet free reportTherapeutics stock downResearch capital

Zevra Therapeutics (ZVRA) Scheduled to Post Quarterly Earnings on Wednesday

Zevra Therapeutics (ZVRA) Scheduled to Post Quarterly Earnings on Wednesday
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairZevra therapeutics incMaxim groupZevra therapeutics company profileCantor fitzgeraldZevra therapeuticsGet free reportLigand activated therapyZevra therapeutics daily

Head-To-Head Survey: Zevra Therapeutics (NASDAQ:ZVRA) versus Daré Bioscience (NASDAQ:DARE)

Head-To-Head Survey: Zevra Therapeutics (NASDAQ:ZVRA) versus Daré Bioscience (NASDAQ:DARE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoKempharm incZevra therapeutics incBioscience incZevra therapeuticsGet free reportGiven darLigand activated therapyCommave therapeuticsSildenafil creamZevra therapeutics daily